Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Oral suspension formulation of Trileptal soon to be available in Europe

Aug. 28, 2001

Two centers added to 12-week study of Neotrofin in spinal cord injury

Aug. 28, 2001

Old drugs may be new therapy for Creutzfeldt-Jakob and other prion diseases

Aug. 28, 2001

Ultracet combination analgesic approved by FDA for acute pain relief

Aug. 27, 2001

Testosterone protects human primary neurons from apoptosis

Aug. 27, 2001

CV Technologies' combination herbal product shows efficacy in ADHD

Aug. 24, 2001

Schering-Plough identifies novel selective NK1 receptor antagonists

Aug. 23, 2001

CRF receptor antagonists reported by researchers at Eisai

Aug. 23, 2001

FDA approves labeling change for Pfizer's Zoloft

Aug. 22, 2001

University of Nebraska researchers disclose novel selective NMDA receptor modulating agents

Aug. 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...